Czech Republic
France
Germany
Norway
Netherlands
Spain
Turkey
United KingdomUpdates
SUB-TYPE: COMPANY-LED RECALL
Company Led Recall - Sodium Chloride Eye Drops 5% 1x10ml
Stockport Pharmaceuticals are recalling a batch of Sodium Chloride Eye Drops 5% w/v as the sterile eye droppers supplied with the medicinal product have expired (January 2022).
MHRA drug alert date: 8 August 2022
MHRA drug alert link:
Pip code | Product | Supplier | Affected Batches |
ALLIANCE DO NOT STOCK | Sodium Chloride Eye Drops 5% 1x10ml | Stockport Pharmaceuticals | C104308 |
Alliance do not stock this product and therefore we are not accepting stock returns.
Company Contact for medical information enquiries
For medical information enquiries, please contact:
Emma Joy Wraith
Head of Quality Assurance
Email: Emma-joy.wraith@stockport.nhs.uk
Company Contact for stock enquiries
For stock information enquiries, please contact:
Andrew Singleton
Head of Production
Email: Andrew.singleton@stockport.nhs.uk
Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.
SUB-TYPE: CLASS 1 RECALL
CLASS 1 RECALL - MEXILETINE HYDROCHLORIDE 50MG, 100MG AND 200MG HARD CAPSULES
Clinigen Healthcare Ltd is initiating a recall of three batches of Mexiletine hydrochloride hard capsules due to a potential risk of underdose or overdose, which could have consequences for the safety of patients.
MHRA drug alert date: 4 August 2022
MHRA drug alert link:
Pip code | Product description | Livery | Batch Numbers |
8040990 | MEXILETINE CAP 50MG (84) | CLINIGEN HEALTHCARE LTD | 2111216 |
8041006 | MEXILETINE CAP 100MG (84) | CLINIGEN HEALTHCARE LTD | 2111217 |
8041014 | MEXILETINE CAP 200MG (100) | CLINIGEN HEALTHCARE LTD | 2111218 |
Further information
For more information or stock and resupply queries, please contact Quantum Pharmaceutical +44 (0) 1207 279 400 or email enquiries@quantumpharma.co.uk
For medical information queries, please contact Clinigen Medical Information on +44 (0) 1932 824 026 or email medicalinformation@clinigengroup.com
For all other enquires place contact Clinigen Healthcare Ltd on +44 (0) 1283 494 340 or email medicineaccess@clinigengroup.com
Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.
Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.
SUB-TYPE: CLASS 4 CAUTION IN USE
Class 4 Drug Caution In Use - Niquitin 14mg Clear Patch x 14
Omega Pharma Limited have identified an error relating to the product packaging. In the ‘Ingredients’ section on the base of the carton, the patch dosage is stated as providing 21mg of nicotine per day. The correct dosage is 14mg per day. The other dosage indications on the carton, the sachets, PIL and SmPC are correct. There is no issue with the product quality and the batch is not being recalled.
MHRA drug alert date: 20 July 2022
MHRA drug alert link:
Pip code | Product Description | Supplier | Batch Numbers |
4089983 | NIQUITIN PATCH CLEAR 14MG X 14 | OMEGA PHARMA LIMITED | 0370102 1110101 |
This is a caution in use only we are not accepting stock returns - if any defective stock is found it should be returned directly to the manufacturer.
Further Information
For medical information and stock control queries please contact: uklocustomerservice@perrigo.com
SUB-TYPE: CLASS 4 CAUTION IN USE
Class 4 Drug Caution In Use - NovoRapid FlexTouch 100 units/ml and Saxenda FlexTouch® (liraglutide) 6mg/ml
Novo Nordisk Limited would like to notify you of a defect that affects specific batches of NovoRapid FlexTouch prefilled pen device and batches of Saxenda FlexTouch prefilled pen device in the UK. The defect results in a non-functioning device where it is not possible to set a dose because the dose selector will spin freely, as such, click sounds will not be heard. Since a dose cannot be selected, the patient cannot inject a dose. A very small number of pens are affected – the average number of affected products is 2-3 pens per million pens. Based on the critical need for the products, they are not being recalled.
MHRA drug alert date: 21 July 2022
MHRA drug alert link:
Pip code | Product Description | Supplier | Batch Numbers |
3667698 | INS NOVORAPID FLEXTOUCH X 5 | NOVO NORDISK LIMITED | MZF0M05 MZF1H04 |
4154209 | SAXENDA 6MG/ML PREFILLED PEN 3ML X 3 | NOVO NORDISK LIMITED | LZF0H19 LZF0D36 LZFW142 MZF0V95 |
4028676 | SAXENDA 6MG/ML PREFILLED PEN 3ML X 5 | NOVO NORDISK LIMITED | LZFW572 LZF0D41 LZFW571 LZFY408 LZFY613 MZF1B51 |
This is a caution in use only we are not accepting stock returns - if any defective stock is found it should be returned directly to Novo Nordisk Limited.
Further Information
For medical information and stock control queries please contact: Customer Care contact details +44 (0)800 023 2573 or CustomerCare@novonordisk.com
SUB-TYPE: CLASS 2 RECALL
Class 2 Recall - Amiodarone Hydrochloride 50mg/ml Concentrate for Solution for Injection/Infusion
Hameln pharma ltd is initiating a recall of batch 207506 of Amiodarone Hydrochloride 50 mg/ml Concentrate for Solution for Injection/Infusion as a precautionary measure. This is due to an increased presence of visible crystalline particles within the solution, identified during ongoing re-inspection of retained samples.
MHRA drug alert date: 19 July 2022
MHRA drug alert link:
Pip code | Product Description | Supplier | Batch Numbers |
ALLIANCE DO NOT STOCK | AMIODARONE HYDROCHLORIDE 50 MG/ML CONCENTRATE FOR SOLUTION FOR INJECTION-INFUSION | HAMELN PHARMA LTD | 207506 |
Alliance do not stock the above product so we will not be accepting Customer returns on this recall.
Further Information
For more information or supply queries, please contact or email Hameln pharma ltd customer services on +44 (0)1452 621 661 or customer.services@hameln-pharma.co.uk
For medical information queries, please contact or email Hameln pharma ltd Medicines Information on +44 (0)1452 621 661 or drug.safety@hameln-pharma.co.uk
SUB-TYPE: CLASS 4 CAUTION IN USE
Class 4 Drug Caution In Use - Covonia Night Time Formula & Covonia Original Bronchial Balsam
Thornton & Ross have identified that the product labelling for some batches of ‘Pharmacy’ medicines do not contain the ‘P’ symbol, due to a packaging error on the bottle.
MHRA drug alert date: 14 July 2022
MHRA drug alert link:
| Pip code | Product Description | Supplier | Batch Numbers |
| 2469385 | Covonia Night Time Formula 150ml (P) | Thornton & Ross | 00JE 80JG |
| 322537 | Covonia Original Bronchial Balsam 150ml (P) | Thornton & Ross | 69KE 81KR |
This is a caution in use only we are not accepting stock returns.
Further Information
For medical information or stock control queries please contact : Thornton & Ross on 01484 842217 or thorntonross@medinformation.co.uk
SUB-TYPE: COMPANY-LED RECALL
Company Led Recall - Linoforce granules 12 years plus
A.Vogel Ltd is recalling the above batch of Pharmacy only medicine due to a small number of packs that were inadvertently supplied to non-pharmacy retail outlets.
This recall is being issued as a company-led medicines recall as this product is only supplied to several outlets, and the manufacturer has full traceability of the onward distribution by their customers.
Remaining stock of the above batch should be quarantined and returned to the company directly.
MHRA drug alert date: 22 June 2022
MHRA drug alert link:
Pip code | Product | Supplier | Affected Batches |
ALLIANCE DO NOT STOCK | LINOFORCE GRANULES 12 YEARS PLUS | A.VOGEL LTD | 1064615 |
Alliance do not stock this product and therefore we are not accepting stock returns.
For medical information enquiries, please contact:
Gillian Forrest
A..Vogel Ltd
2 Brewster Place
Irvine
Ayrshire
KA11 5DD
Email: gillian@avogel.co.uk
For stock information enquiries, please contact:
Debbie Martin
A.Vogel Ltd
2 Brewster Place
Irvine
Ayrshire
KA11 5DD
Email: debbie@avogel.co.uk
Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.
SUB-TYPE: COMPANY-LED RECALL
Company Led Recall - Invita D3 800 IU Soft Capsules (28)
Consilient Health UK Ltd is recalling a specific batch due to limited units from the batch being distributed prior to batch release.
Limited number of units from the batch were distributed prior to batch release. There are no indications of any quality of safety concerns and this recall is precautionary due to the regulatory non-compliance.
This recall is being issued as a company-led medicines recall, as this product is only supplied to several pharmacies and the company has traceability of the onward distribution by their customers.
Remaining stock of the above batch should be quarantined and returned to the company directly.
MHRA drug alert date: 30 May 2022
MHRA drug alert link:
Pip code | Product description | Supplier | Affected Batches |
4039764 | INVITA D3 800 IU CAP (28) | CONSILIENT HEALTH UK LTD | 1389492 |
Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.
Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.
If you have any questions, then please contact your local Service Centre Customer Services team.
SUB-TYPE: CLASS 2 RECALL
Class 2 Recall - Phenobarbital 60mg Tablets
Bristol Laboratories Limited are recalling the below batch of product as a precautionary measure due to low dissolution test results reported during ongoing stability studies.
MHRA drug alert date: 13 June 2022
Pip code | Product Description | Supplier | Batch Numbers |
ALLIANCE DO NOT STOCK | PHENOBARBITAL 60MG TABLETS | BRISTOL LABORATORIES LIMITED | NW0001 |
Alliance do not stock the above product so we will not be accepting Customer returns on this recall.
Further Information
For more information, medical or supply enquiries, please contact notifications@bristol-labs.co.uk
Recipients of this Medicines Recall should bring it to the attention of relevant contacts by copy of this notice.
SUB-TYPE: CLASS 2 RECALL
Class 2 Recall - Water for Injections BP – 100ml vial x 25
Hameln pharma ltd are recalling batches of product additional to the batch recalled on 15 February 2022 (reference EL(22)A/06). This recall is conducted as a precautionary measure, as remaining vials may no longer be in line with the licensed product specification with respect to the parameters pH and conductivity.
MHRA drug alert date: 25 May 2022
Pip code | Product description | Supplier | Batch Numbers |
0769489 | WATER FOR INJ BP VIAL R/C 100ML (25) | HAMELN PHARMACEUTICALS LTD (MOV) | 019501 019502 019503 019504 019505 019506 920503 920506 920508 930503 930504 930505 931501 940501 940502 951504 952501 |
Further Information
For more information, medical or supply enquiries, please contact: drug.safety@hameln-pharma.co.uk
For stock control queries, please contact: customer.services@hameln-pharma.co.uk
Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.
Please note that anything not returned to us, or notified to us, within 3 months of this notification by the 26 August 2022, cannot be reimbursed by way of a credit